Current Colorectal Cancer Reports

, Volume 7, Issue 1, pp 42–49 | Cite as

Hyperplastic Polyps: Are They Completely Innocent?

Article

Abstract

Until recently, all serrated polyps were classified simply as hyperplastic polyps and were thought to represent benign lesions with no progression to malignancy. However, the recognition during the last decade that some serrated polyps may progress to colorectal cancer through the “serrated neoplastic pathway” has changed the understanding of the significance of these lesions. Classification of serrated polyps is evolving and underscores the fact that morphological changes in serrated lesions are linked to a preneoplastic behavior. This fact has been observed not only in the hyperplastic polyposis syndrome, characterized by multiple or large serrated polyps, but also in the sporadic setting. These findings are particularly important for colorectal cancer prevention, and adequate surveillance programs tailored for patients with serrated polyps are urgently needed.

Keywords

Hyperplastic polyps Serrated polyps Serrated pathway Colorectal cancer Surveillance Hyperplastic polyposis BRAF CIMP 

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    •• O’Brien MJ: Hyperplastic and serrated polyps of the colorectum. Gastroenterol Clin North Am 2007,36:947–968. This article reviews the histological classification of serrated polyps and their molecular associations. CrossRefPubMedGoogle Scholar
  2. 2.
    Chow E, Lipton L, Lynch E, et al.: Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology 2006,131:30–39.CrossRefPubMedGoogle Scholar
  3. 3.
    • Boparai KS, Mathus-Vliegen EM, Koornstra JJ, et al.: Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study. Gut 2010;59:1094–1100. This article describes the CRC risk in the largest cohort of HPS patients published so far. CrossRefPubMedGoogle Scholar
  4. 4.
    Iino H, Jass JR, Simms LA, et al.: DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? J Clin Pathol 1999,52:5–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Hawkins NJ, Ward RL: Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. Journal of the National Cancer Institute 2001,93:1307–1313.CrossRefPubMedGoogle Scholar
  6. 6.
    Toyota M, Ahuja N, Ohe-Toyota M, et al.: CpG island methylator phenotype in colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America 1999,96:8681–8686.CrossRefPubMedGoogle Scholar
  7. 7.
    Wynter CV, Walsh MD, Higuchi T, et al.: Methylation patterns define two types of hyperplastic polyp associated with colorectal cancer. Gut 2004,53:573–580.CrossRefPubMedGoogle Scholar
  8. 8.
    Jones PA, Laird PW: Cancer epigenetics comes of age. Nature genetics 1999,21:163–167.CrossRefPubMedGoogle Scholar
  9. 9.
    Chan TL, Zhao W, Leung SY, Yuen ST: BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer research 2003,63:4878–4881.PubMedGoogle Scholar
  10. 10.
    Kambara T, Simms LA, Whitehall VL, et al.: BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 2004,53:1137–1144.CrossRefPubMedGoogle Scholar
  11. 11.
    • Leggett B, Whitehall V: Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology,138:2088–2100. This recent and complete review focuses on the significance of the serrated pathway in colorectal carcinogenesis. Google Scholar
  12. 12.
    Glazer E, Golla V, Forman R, et al.: Serrated adenoma is a risk factor for subsequent adenomatous polyps. Dig Dis Sci 2008,53:2204–2207.CrossRefPubMedGoogle Scholar
  13. 13.
    Laiyemo AO, Murphy G, Sansbury LB, et al.: Hyperplastic polyps and the risk of adenoma recurrence in the polyp prevention trial. Clin Gastroenterol Hepatol 2009,7:192–197.CrossRefPubMedGoogle Scholar
  14. 14.
    Lazarus R, Junttila OE, Karttunen TJ, Makinen MJ: The risk of metachronous neoplasia in patients with serrated adenoma. Am J Clin Pathol 2005,123:349–359.CrossRefPubMedGoogle Scholar
  15. 15.
    • Hiraoka S, Kato J, Fujiki S, et al.: The Presence of Large Serrated Polyps Increases Risk for Colorectal Cancer. Gastroenterology 2010,139:1503–1510. This article includes a large cohort of patients undergoing colonoscopy and describes that the presence of large serrated polyps in the colon is associated with CRC development. CrossRefPubMedGoogle Scholar
  16. 16.
    • Schreiner MA, Weiss DG, Lieberman DA: Proximal and large hyperplastic and non-dysplastic serrated polyps detected by colonoscopy are associated with neoplasia. Gastroenterology 2010,139:1497–1502. This article analyze predictors of advanced colonic neoplasia in a large cohort of patients undergoing colonoscopy, recognizing that the presence of large and proximal serrated polyps are associated with CRC development. CrossRefPubMedGoogle Scholar
  17. 17.
    Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP: Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol 2005,124:380–391.CrossRefPubMedGoogle Scholar
  18. 18.
    Aust DE, Baretton GB: Serrated polyps of the colon and rectum (hyperplastic polyps, sessile serrated adenomas, traditional serrated adenomas, and mixed polyps)-proposal for diagnostic criteria. Virchows Arch 2010,457:291–297.CrossRefPubMedGoogle Scholar
  19. 19.
    Longacre TA, Fenoglio-Preiser CM: Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. The American journal of surgical pathology 1990,14:524–537.CrossRefPubMedGoogle Scholar
  20. 20.
    Torlakovic E, Skovlund E, Snover DC, et al.: Morphologic reappraisal of serrated colorectal polyps. The American journal of surgical pathology 2003,27:65–81.CrossRefPubMedGoogle Scholar
  21. 21.
    Torlakovic E, Snover DC: Serrated adenomatous polyposis in humans. Gastroenterology 1996,110:748–755.CrossRefPubMedGoogle Scholar
  22. 22.
    Torlakovic EE, Gomez JD, Driman DK, et al.: Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). The American journal of surgical pathology 2008,32:21–29.CrossRefPubMedGoogle Scholar
  23. 23.
    Khalid O, Radaideh S, Cummings OW, et al.: Reinterpretation of histology of proximal colon polyps called hyperplastic in 2001. World J Gastroenterol 2009,15:3767–3770.CrossRefPubMedGoogle Scholar
  24. 24.
    Farris AB, Misdraji J, Srivastava A, et al.: Sessile serrated adenoma: challenging discrimination from other serrated colonic polyps. The American journal of surgical pathology 2008,32:30–35.CrossRefPubMedGoogle Scholar
  25. 25.
    Sandmeier D, Seelentag W, Bouzourene H: Serrated polyps of the colorectum: is sessile serrated adenoma distinguishable from hyperplastic polyp in a daily practice? Virchows Arch 2007,450:613–618.CrossRefPubMedGoogle Scholar
  26. 26.
    Carr NJ, Mahajan H, Tan KL, et al.: Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol 2009,62:516–518.CrossRefPubMedGoogle Scholar
  27. 27.
    Spring KJ, Zhao ZZ, Karamatic R, et al.: High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 2006,131:1400–1407.CrossRefPubMedGoogle Scholar
  28. 28.
    O’Brien MJ, Yang S, Mack C, et al.: Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. The American journal of surgical pathology 2006,30:1491–1501.CrossRefPubMedGoogle Scholar
  29. 29.
    Gurudu SR, Heigh RI, De Petris G, et al.: Sessile serrated adenomas: demographic, endoscopic and pathological characteristics. World J Gastroenterol,16:3402–3405.Google Scholar
  30. 30.
    Higuchi T, Sugihara K, Jass JR: Demographic and pathological characteristics of serrated polyps of colorectum. Histopathology 2005,47:32–40.CrossRefPubMedGoogle Scholar
  31. 31.
    Goldstein NS, Bhanot P, Odish E, Hunter S: Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol 2003,119:778–796.CrossRefPubMedGoogle Scholar
  32. 32.
    Jass JR, Baker K, Zlobec I, et al.: Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a ‘fusion’ pathway to colorectal cancer. Histopathology 2006,49:121–131.CrossRefPubMedGoogle Scholar
  33. 33.
    East JE, Saunders BP, Jass JR: Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management. Gastroenterol Clin North Am 2008,37:25–46.CrossRefPubMedGoogle Scholar
  34. 34.
    Ferrandez A, Samowitz W, DiSario JA, Burt RW: Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: case series and literature review. Am J Gastroenterol 2004,99:2012–2018.CrossRefPubMedGoogle Scholar
  35. 35.
    Carvajal-Carmona LG, Howarth KM, Lockett M, et al.: Molecular classification and genetic pathways in hyperplastic polyposis syndrome. The Journal of pathology 2007,212:378–385.CrossRefPubMedGoogle Scholar
  36. 36.
    Jass JR, Iino H, Ruszkiewicz A, et al.: Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut 2000,47:43–49.CrossRefPubMedGoogle Scholar
  37. 37.
    Rashid A, Houlihan PS, Booker S, et al.: Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology 2000,119:323–332.CrossRefPubMedGoogle Scholar
  38. 38.
    Rubio CA, Stemme S, Jaramillo E, Lindblom A: Hyperplastic polyposis coli syndrome and colorectal carcinoma. Endoscopy 2006,38:266–270.CrossRefPubMedGoogle Scholar
  39. 39.
    Kiesslich R, von Bergh M, Hahn M, et al.: Chromoendoscopy with indigocarmine improves the detection of adenomatous and nonadenomatous lesions in the colon. Endoscopy 2001,33:1001–1006.CrossRefPubMedGoogle Scholar
  40. 40.
    Kaltenbach T, Friedland S, Soetikno R: A randomised tandem colonoscopy trial of narrow band imaging versus white light examination to compare neoplasia miss rates. Gut 2008,57:1406–1412.CrossRefPubMedGoogle Scholar
  41. 41.
    Boparai KS, Dekker E, Van Eeden S, et al.: Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis. Gastroenterology 2008,135:2014–2018.CrossRefPubMedGoogle Scholar
  42. 42.
    Jeevaratnam P, Cottier DS, Browett PJ, et al.: Familial giant hyperplastic polyposis predisposing to colorectal cancer: a new hereditary bowel cancer syndrome. The Journal of pathology 1996,179:20–25.CrossRefPubMedGoogle Scholar
  43. 43.
    •• Boparai KS, Reitsma JB, Lemmens V, et al.: Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome. Gut 2010,59:1222–1225. In this article, using a large cohort of first-degree relatives of HPS patients, the authors show that the risk of both CRC and hyperplastic polyposis phenotype is increased in this population. CrossRefPubMedGoogle Scholar
  44. 44.
    Jass JR, Young J, Leggett BA: Hyperplastic polyps and DNA microsatellite unstable cancers of the colorectum. Histopathology 2000,37:295–301.CrossRefPubMedGoogle Scholar
  45. 45.
    Sawhney MS, Farrar WD, Gudiseva S, et al.: Microsatellite instability in interval colon cancers. Gastroenterology 2006,131:1700–1705.CrossRefPubMedGoogle Scholar
  46. 46.
    Lu FI, van Niekerk de W, Owen D, et al.: Longitudinal outcome study of sessile serrated adenomas of the colorectum: an increased risk for subsequent right-sided colorectal carcinoma. The American journal of surgical pathology 2010,34:927–934.CrossRefPubMedGoogle Scholar
  47. 47.
    Li D, Jin C, McCulloch C, et al.: Association of large serrated polyps with synchronous advanced colorectal neoplasia. Am J Gastroenterol 2009,104:695–702.CrossRefPubMedGoogle Scholar
  48. 48.
    Bauer VP, Papaconstantinou HT: Management of serrated adenomas and hyperplastic polyps. Clin Colon Rectal Surg 2008,21:273–279.CrossRefPubMedGoogle Scholar
  49. 49.
    Rex DK, Smith JJ, Ulbright TM, Lehman GA: Distal colonic hyperplastic polyps do not predict proximal adenomas in asymptomatic average-risk subjects. Gastroenterology 1992,102:317–319.PubMedGoogle Scholar
  50. 50.
    Levin B, Lieberman DA, McFarland B, et al.: Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA: a cancer journal for clinicians 2008,58:130–160.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Gastroenterology DepartmentInstitut de Malalties Digestives i Metabòliques, CIBERehd, IDIBAPS, Hospital ClínicBarcelonaSpain

Personalised recommendations